Hide metadata

dc.date.accessioned2023-12-19T16:40:47Z
dc.date.available2023-12-19T16:40:47Z
dc.date.created2023-12-15T23:38:58Z
dc.date.issued2023
dc.identifier.citationFineide, Fredrik Tashbayev, Behzod Elgstøen, Katja B. Prestø Sandås, Elise Mørk Rootwelt, Helge Hynne, Håvard Chen, Xiangjun Ræder, Sten Vehof, Jelle Dartt, Darlene Ann Jensen, Janicke Liaaen Utheim, Tor Paaske . Tear and Saliva Metabolomics in Evaporative Dry Eye Disease in Females. Metabolites. 2023
dc.identifier.urihttp://hdl.handle.net/10852/106496
dc.description.abstractAccurate diagnosis of dry eye disease (DED) is challenging, and even today there is no gold standard biomarker of DED. Hypothesis-free global metabolomic studies of tears from DED patients have great potential to discover metabolites and pathways affected in the pathophysiology of DED, and to identify possible future biomarkers. These metabolites and biomarkers could be important for diagnosing and monitoring disease as well as for new therapeutic targets and strategies. As DED is associated with dry mouth, this study aimed to perform metabolomic analyses of tears and saliva from patients with decreased tear film break-up time but normal Schirmer test, and age-matched controls with both tear production and stability within physiological range. We applied strict inclusion criteria to reduce sampling bias in the metabolomic analyses and selected only age-matched females with Schirmer test values between 10–15 mm/5 min. The tear film analysis arm included 19 patients (with tear film break-up time 0–5 s) and 12 controls (with tear film break-up time 10–30 s), while the salivary analysis arm consisted of a subset which included 18 patients and six controls. Metabolomic analyses were performed using liquid chromatography and high-resolution mass spectrometry. Analyses using a global database search detected a total of 56 metabolites in tear samples that were significantly different between the groups. Of these, several have known associations with DED. These metabolites are present in meibum and have anti-oxidative characteristics or associations with the ocular microbiome, and altered concentrations suggest that they may play a significant role in DED associated with decreased tear film stability. In saliva, hypotaurine levels were lower among patients with tear film instability. In this pilot study, we found different levels of several metabolites in patients with decreased tear film break-up time that may have associations with DED. Future studies are required to replicate our findings and clarify the exact roles of these metabolites.
dc.languageEN
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleTear and Saliva Metabolomics in Evaporative Dry Eye Disease in Females
dc.title.alternativeENEngelskEnglishTear and Saliva Metabolomics in Evaporative Dry Eye Disease in Females
dc.typeJournal article
dc.creator.authorFineide, Fredrik
dc.creator.authorTashbayev, Behzod
dc.creator.authorElgstøen, Katja B. Prestø
dc.creator.authorSandås, Elise Mørk
dc.creator.authorRootwelt, Helge
dc.creator.authorHynne, Håvard
dc.creator.authorChen, Xiangjun
dc.creator.authorRæder, Sten
dc.creator.authorVehof, Jelle
dc.creator.authorDartt, Darlene Ann
dc.creator.authorJensen, Janicke Liaaen
dc.creator.authorUtheim, Tor Paaske
cristin.unitcode185,16,17,51
cristin.unitnameOral kirurgi og oral medisin
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin2214371
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Metabolites&rft.volume=&rft.spage=&rft.date=2023
dc.identifier.jtitleMetabolites
dc.identifier.volume13
dc.identifier.issue11
dc.identifier.doihttps://doi.org/10.3390/metabo13111125
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn2218-1989
dc.type.versionPublishedVersion
cristin.articleid1125


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International